Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to support people with early stages of Type 1 Diabetes.

The National Institute for Health and Care Excellence (NICE) is developing guidance on the use of Teplizumab for delaying the onset of stage 3 type 1 diabetes in people eight years and over with stage 2 type 1 diabetes. Further information can be found on NICE’s website, and is available at the following link:

https://www.nice.org.uk/guidance/indevelopment/gid-ta10981.

The expected publication date of the guidance is 26 November 2025.